Alkermes' Corporate Presentation to be Webcast at the UBS Global Healthcare Conference

DUBLIN--(BUSINESS WIRE)--May 11, 2015-- Alkermes plc (NASDAQ: ALKS) announced today that its corporate presentation will be webcast live at the UBS Global Healthcare Conference on Monday, May 18, 2015, at 2:00 p.m. EDT (7:00 p.m. BST) from the Sheraton New York Hotel. The presentation may be accessed under the Investors tab on www.alkermes.com and will be archived for 14 days.

Alkermes plc is a fully integrated, global biopharmaceutical company developing innovative medicines for the treatment of central nervous system (CNS) diseases. The company has a diversified commercial product portfolio and a substantial clinical pipeline of product candidates for chronic diseases that include schizophrenia, depression, addiction and multiple sclerosis.Dublin, Ireland, Alkermes plc has an R&D center in Waltham, Massachusetts; a research and manufacturing facility in Athlone, Ireland; and a manufacturing facility in Wilmington, Ohio. For more information, please visit Alkermes' website at www.alkermes.com.

Source: Alkermes plc

For Alkermes
Eva Stroynowski, +1 781 609 6823
Corporate Communications

distributed by